VIDEO: Abrocitinib safe and efficacious in AD patients with or without allergic comorbidities
- Jeremy Visser
- Dec 13, 2023
- 1 min read
According to a recent study, abrocitinib is efficacious and well tolerated in atopic dermatitis (AD) patients with or without allergic comorbidities.
Comments